Clinical Trial Update: Bortezomib Consolidation Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating bortezomib as consolidation therapy in multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: University College, London | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED